Navigation Links
Reprogrammed Herpes Virus Given Systemically Before Anti-vascular Drug Shrinks Distant Sarcomas
Date:7/7/2010

involving combination therapeutic strategies, Dr. Cripe said. Clinical trials are underway in the United States and Europe using oncolytic herpes viruses similar to the one used in the current study.

Other researchers involved in the current study include the first author, Francis Eshun, M.D., and Mark Currier, Rebecca Gillespie, Jillian Fitzpatrick and William Baird, all of the Division of Hematology/Oncology at Cincinnati Children's and its Cancer and Blood Diseases Institute. Funding support for the study from the Cincinnati Children's Division of Hematology/Oncology, teeoffagainstcancer.org, the Katie Linz Foundation, the Limb Preservation Foundation, the American Cancer Society and the National Institutes of Health.

About Cincinnati Children's

Cincinnati Children's Hospital Medical Center is one of just eight children's hospitals named to the Honor Roll in U.S. News and World Report's 2010-11 Best Children's Hospitals. It is ranked #1 for digestive disorders and highly ranked for its expertise in pulmonology, cancer, neonatology, heart and heart surgery, neurology and neurosurgery, diabetes and endocrinology, orthopedics, kidney disorders and urology. Cincinnati Children's is one of the top two recipients of pediatric research grants from the National Institutes of Health. It is internationally recognized for quality and transformation work by Leapfrog, The Joint Commission, the Institute for Healthcare Improvement, the federal Agency for Healthcare Research and Quality, and by hospitals and health organizations it works with globally. Additional information can be found at

SOURCE Cincinnati Children's Hospital Medical Center
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs
2. Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes
3. BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes
4. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
5. NanoBio Corporation Successfully Completes Phase 2b Study in Herpes Labialis
6. NanoBio Corporation Presents Preclinical and Interim Clinical Data on Topical Treatments for Herpes Labialis and Onychomycosis at AAD 2008
7. Data From LigoCytes Clinical Studies of Norovirus VLP Vaccine Presented at 13th Annual Conference on Vaccine Research
8. Components of Extraneous Virus Detected in Rotarix Vaccine; No Known Safety Risk
9. Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
10. Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)
11. Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... SOUTH PLAINFIELD, N.J. , May 16, 2013 /PRNewswire/ ... a registration statement on Form S-1 with the U.S. ... initial public offering of its common stock. The number ... for the offering have not been determined. ... and Credit Suisse are acting as joint book-running managers ...
(Date:5/16/2013)... Mass. and SYDNEY , May ... - ASX: HIN), a leading innovator of less invasive, ... advanced heart failure, today announced that CEO Doug ... UBS Global Healthcare Conference at 11:00 a.m. EDT on Monday, ... 2013 at the Sheraton New York Hotel. A ...
(Date:5/16/2013)... , May 16, 2013 AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for the treatment ... Richard King , President and CEO, will present a ... Sheraton New York Hotel in New York ... 2013 at 9:30 a.m. ET/6:30 a.m. PT. The ...
Breaking Medicine Technology:PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference 2AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference 3
... N.Y., Dec. 1, 2011  Regeneron Pharmaceuticals, Inc. (Nasdaq: ... Company,s presentation at the 2011 Deutsche Bank BioFEST scheduled ... for 1:05 p.m. Eastern Time.  The session may be ... on the Investor Relations page.  An archived version of ...
... Ill., Dec. 1, 2011   Sysmex America, Inc., a global ... technology, today announces that the company has been named ... 100 Best Places to Work in Healthcare , ranking ... overall.  Results were based on company application and employee ...
Cached Medicine Technology:Regeneron Announces Presentation Time Change at the 2011 Deutsche Bank BioFEST 2Sysmex America Earns Spot on Top 100 Best Places to Work in Healthcare 2Sysmex America Earns Spot on Top 100 Best Places to Work in Healthcare 3
(Date:5/18/2013)... FRIDAY, May 17 (HealthDay News) -- It comes as little ... shows that college women are more likely to drink unhealthy ... men. Much of this difference is probably because ... basis is much lower for women than it is for ... there,s good reason for that difference. Women don,t metabolize alcohol ...
(Date:5/18/2013)... TheBeautyPlace.com answers important questions about the hairloss products ... result of stress, nutrient deficiency or wearing a favorite ... men suffer from male patterned baldness. , ... transplant surgery, but additionally carries a hair care product ... Professional Strength. Their product line is a five-step treatment ...
(Date:5/18/2013)... During Better Hearing and Speech Month, parents ... protections they have, including the right to bring a ... treatment or hearing aid device, attorney Ronald E. Johnson ... Association has used the month of May to raise ... as cochlear implants, which can improve the quality of ...
(Date:5/18/2013)... The “Sleep Apnea Diagnostic & Therapeutic Devices Market ... (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] Global End-user Analysis, ... the major market drivers, restraints, and opportunities in North ... Browse , 147 market data ... 318 pagesand in-depth TOC of “Sleep ...
(Date:5/18/2013)... Show And Go Training, the culmination of Eric ... that is all about is getting results in the fastest ... http://ShowAndGoTrainingReview.com ’s Stan Stevenson, prompting an investigative review. , ... phase system” designed to make you faster, stronger, fitter and ... out in the gym. The training manual and exercise video ...
Breaking Medicine News(10 mins):Health News:College Women More Prone to Problem Drinking Than Men: Study 2Health News:College Women More Prone to Problem Drinking Than Men: Study 3Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 2Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 3Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2
... Health Information System via Remote Hosting Services to Improve ... , CINCINNATI, Dec. 9 Streamline ... announced that it will integrate its enterprise document ... of Massena Memorial Hospital, a leading quality health care ...
... , The following ... Recently there has been a ... our healthcare delivery system. We are told there are 46 ... are,calling for immediate government intervention with a nationalized healthcare,rescue plan ...
... Real-Time Linking to Lexi-Comp Drug Resources for Mutual Subscribers ... ... 2008 -- Institutions subscribing to DynaMed™ , or other ... able to seamlessly access real-time information from their Lexi-Comp ...
... over but Australian champion runner Craig Mottram had one more challenge to ... ... (PRWEB) December 9, 2008 -- The historic inaugural HBA Great Australian Run ... challenge to complete. , , , , ,Mottram, who was competing ...
... Cell Therapeutics, Inc.,(Nasdaq and MTA: CTIC) announced today ... ([90Y]-ibritumomab tiuxetan) were,presented at the American Society of Hematology ... In one presentation, the ... the use of single dose Zevalin as sole initial ...
... PLEASANTON, Calif., Dec. 8 Roche Molecular Diagnostics,announced today ... new,COBAS(R) AmpliPrep / COBAS(R) TaqMan(R) HBV Test v2.0, allowing ... Union. This highly sensitive test offers,Roche,s fully automated ... the quantitative detection of hepatitis B virus (HBV) DNA ...
Cached Medicine News:Health News:Streamline Health(R) Announces Massena Memorial Hospital to Implement Enterprise Document Workflow Solutions 2Health News:Streamline Health(R) Announces Massena Memorial Hospital to Implement Enterprise Document Workflow Solutions 3Health News:Streamline Health(R) Announces Massena Memorial Hospital to Implement Enterprise Document Workflow Solutions 4Health News:Streamline Health(R) Announces Massena Memorial Hospital to Implement Enterprise Document Workflow Solutions 5Health News:Average Americans Without Health Insurance Are Young and Healthy With Above Average Incomes 2Health News:EBSCO Publishing and Lexi-Comp Formalize Product Partnership to Enable Seamless Integration Between Products 2Health News:EBSCO Publishing and Lexi-Comp Formalize Product Partnership to Enable Seamless Integration Between Products 3Health News:EBSCO Publishing and Lexi-Comp Formalize Product Partnership to Enable Seamless Integration Between Products 4Health News:Mottram Honours His End of the HBA Great Australian Run challenge 2Health News:Three Italian Multicenter Studies Report High (>70%) Rates of Complete Remission (CR) Utilizing Zevalin Radio-Immunotherapy (RIT) in Treatment of Newly Diagnosed or Relapsed or Refractory Non-Hodgkin's Lymphoma 2Health News:Three Italian Multicenter Studies Report High (>70%) Rates of Complete Remission (CR) Utilizing Zevalin Radio-Immunotherapy (RIT) in Treatment of Newly Diagnosed or Relapsed or Refractory Non-Hodgkin's Lymphoma 3Health News:Three Italian Multicenter Studies Report High (>70%) Rates of Complete Remission (CR) Utilizing Zevalin Radio-Immunotherapy (RIT) in Treatment of Newly Diagnosed or Relapsed or Refractory Non-Hodgkin's Lymphoma 4Health News:Three Italian Multicenter Studies Report High (>70%) Rates of Complete Remission (CR) Utilizing Zevalin Radio-Immunotherapy (RIT) in Treatment of Newly Diagnosed or Relapsed or Refractory Non-Hodgkin's Lymphoma 5Health News:Improved Testing for Hepatitis B Virus From Roche 2Health News:Improved Testing for Hepatitis B Virus From Roche 3
Weitlaner-Locktite retractors, blunt, 11 cm total length....
Weitlaner Beckmann retractor, sharp prongs, SS....
Weitlaner retractor, blunt....
Daubenspeck sharp curette, 8....
Medicine Products: